Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Alonso

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
The Lancet Regional Health. Europe|April 14, 2025
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trialAurora Páez-Vega, José M Vaquero-Barrios, Elisa Ruiz-Arabi, et al.
Circulation|March 10, 2017
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, et al.
Microbiology Spectrum|November 10, 2022
Genetic Study of SARS-CoV-2 Non Structural Protein 12 in COVID-19 Patients Non Responders to RemdesivirMarta Santos Bravo, Rodrigo Alonso, Dafne Soria, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 17, 2026
The Need for Clarity Among the Shadows: It Is time to Further Refine the Definition of Primary Graft Dysfunction in Lung Transplant RecipientsAnil J Trindade, Ciara M Shaver, Caitlin T Demarest, et al.
Journal of Clinical Lipidology|May 14, 2018
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART studyLeopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, et al.
Current Medical Research and Opinion|October 26, 2016
Statin-associated muscle symptoms: position paper from the Luso-Latin American ConsortiumAndrei C Sposito, José Rocha Faria Neto, Luiz Sergio F de Carvalho, et al.
Journal of Clinical Lipidology|November 11, 2019
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART studyLeopoldo Pérez de Isla, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, et al.
Infectious Diseases and Therapy|April 27, 2022
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control StudyRodrigo Alonso, Ana M Camon, Celia Cardozo, et al.
International Journal of Cardiology|May 30, 2017
Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)Carlos I Ponte-Negretti, Jesus E Isea-Perez, Alberto J Lorenzatti, et al.
The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
The Lancet Regional Health. Europe|April 14, 2025
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trialAurora Páez-Vega, José M Vaquero-Barrios, Elisa Ruiz-Arabi, et al.
Circulation|March 10, 2017
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, et al.
Microbiology Spectrum|November 10, 2022
Genetic Study of SARS-CoV-2 Non Structural Protein 12 in COVID-19 Patients Non Responders to RemdesivirMarta Santos Bravo, Rodrigo Alonso, Dafne Soria, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 17, 2026
The Need for Clarity Among the Shadows: It Is time to Further Refine the Definition of Primary Graft Dysfunction in Lung Transplant RecipientsAnil J Trindade, Ciara M Shaver, Caitlin T Demarest, et al.
Journal of Clinical Lipidology|May 14, 2018
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART studyLeopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, et al.
Current Medical Research and Opinion|October 26, 2016
Statin-associated muscle symptoms: position paper from the Luso-Latin American ConsortiumAndrei C Sposito, José Rocha Faria Neto, Luiz Sergio F de Carvalho, et al.
Journal of Clinical Lipidology|November 11, 2019
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART studyLeopoldo Pérez de Isla, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, et al.
Infectious Diseases and Therapy|April 27, 2022
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control StudyRodrigo Alonso, Ana M Camon, Celia Cardozo, et al.
International Journal of Cardiology|May 30, 2017
Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)Carlos I Ponte-Negretti, Jesus E Isea-Perez, Alberto J Lorenzatti, et al.
The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.
Pageof 23